Two years after initial rejection, Akebia ’s anemia drug finally gets FDA approval
The FDA approved the Cambridge biotech's drug vadadustat for the treatment of anemia due to chronic kidney disease in adults who have been receiving dialysis for at least three months.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Hannah Green Source Type: news
More News: Anemia | Biotechnology | Chronic Kidney Disease | Dialysis | Health Management | Urology & Nephrology